Feedback / Questions
filgotinib (GLPG0634) - Gilead
Filgotinib: Data from P2b/3 SELECTION1 trial (NCT02914522) for ulcerative colitis in Q2 2020
(Gilead)
-
Oct 25, 2019 -
Q3 2019 Results
P2/3 data
http://investors.gilead.com/static-files/4def9c84-f211-4174-af31-b3eef879ab29
Oct 25, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious